Diridavumab

Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research of H2 influenza virus.
Read more
€0.00 (tax incl.)
Reference:
HY-P99853
Product Details
HY-P99853

Data sheet

Size
Multiple sizes
Reactivity
Influenza Virus
CAS
1393659-46-5

Menu

Settings